Description
Antibody Name: | Anti-SARS-CoV-2 Spike S1 Antibody (CAB20834) |
Antibody SKU: | CAB20834 |
Antibody Size: | 50µL, 100µL |
Application: | Western blotting, Immunofluorescence |
Reactivity: | SARS-CoV-2 |
Host Species: | Rabbit |
Immunogen: | A synthetic peptide corresponding to a sequence within amino acids 200-300 of SARS-CoV-2 Spike S1 (YP_009724390.1). |
Application: | Western blotting, Immunofluorescence |
Recommended Dilution: | WB 1:500 - 1:2000 IF 1:50 - 1:200 |
Reactivity: | SARS-CoV-2 |
Positive Samples: | 293T |
Immunogen: | A synthetic peptide corresponding to a sequence within amino acids 200-300 of SARS-CoV-2 Spike S1 (YP_009724390.1). |
Purification Method: | Affinity purification |
Storage Buffer: | Store at -20°C. Avoid freeze / thaw cycles. Buffer: PBS with 0.02% sodium azide, 0.05% BSA, 50% glycerol, pH7.3. |
Isotype: | IgG |
Sequence: | YFKI YSKH TPIN LVRD LPQG FSAL EPLV DLPI GINI TRFQ TLLA LHRS YLTP GDSS SGWT AGAA AYYV GYLQ PRTF LLKY NENG TITD AVDC ALDP LSET K |
Cellular Location: | |
Calculated MW: | |
Observed MW: | 110KDa |
Synonyms: | |
Background: | The spike (S) glycoprotein of coronaviruses contains protrusions that will only bind to certain receptors on the host cell. The spike is essential for both host specificity and viral infectivity. The spike (S) glycoprotein of coronaviruses is known to be essential in the binding of the virus to the host cell at the advent of the infection process. It''s been reported that SARS-CoV-2 (COVID-19 coronavirus, 2019-nCoV) can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. The main functions for the Spike protein are summarized as: Mediate receptor binding and membrane fusion; Defines the range of the hosts and specificity of the virus; Main component to bind with the neutralizing antibody; Key target for vaccine design; Can be transmitted between different hosts through gene recombination or mutation of the receptor binding domain (RBD), leading to a higher mortality rate. |
Western blot analysis of extracts of 293T cells, using SARS-CoV-2 Spike S1 antibody at 1:10000-1:2560000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit. Exposure time: 30s. | |
Immunofluorescence analysis of 293T cells transfected with S1 and untreated 293T cells using SARS-CoV-2 Spike S1 Rabbit mAb at dilution of 1:100 (40x lens). Blue: DAPI for nuclear staining. | |
Western blot analysis of extracts of 293T cells, using SARS-CoV-2 Spike S1 antibody at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit. Exposure time: 10s. |